NCT07238699 An Evaluation of the Safety and Tolerability of Ocular Lubricants
| NCT ID | NCT07238699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alcon Research |
| Condition | Dry Eye Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 148 participants |
| Start Date | 2026-03-04 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 148 participants in total. It began in 2026-03-04 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye disease.
Eligibility Criteria
Inclusion Criteria: * Subject must be willing and able to understand and sign an ethics committee approved informed consent form. * Subject must be willing and able to attend all study visits as required by the protocol. * Subject must exhibit symptoms of dry eye at the Screening Visit. * Subject must currently use artificial tears. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Has any known active ocular disease and/or infection. * Has any known infection or inflammation that requires treatment or has a systemic condition that, in the opinion of the investigator, may affect a study outcome variable. * Any ocular injury to either eye in the 12 weeks prior to screening. * Current wearer of contact lenses or has a history of contact lens wear within the previous 1 month. * Other protocol-defined exclusion criteria may apply.
Contact & Investigator
Clinical Trial Lead, Dry Eye
STUDY DIRECTOR
Alcon Research, LLC
Frequently Asked Questions
Who can join the NCT07238699 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dry Eye Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07238699 currently recruiting?
Yes, NCT07238699 is actively recruiting participants. Contact the research team at alcon.medinfo@alcon.com for enrollment information.
Where is the NCT07238699 trial being conducted?
This trial is being conducted at Sydney, Australia, Teneriffe, Australia, Carlton, Australia, Waurn Ponds, Australia.
Who is sponsoring the NCT07238699 clinical trial?
NCT07238699 is sponsored by Alcon Research. The principal investigator is Clinical Trial Lead, Dry Eye at Alcon Research, LLC. The trial plans to enroll 148 participants.